Pharma companies still searching for answers on gender diversity
Women Count 2017 has tracked and analysed the number of women, finding that progress on gender diversity in senior roles has regressed...
List view / Grid view
News
Numerous manufacturing and process industries stand to benefit from HORIBA’s fully automatic and self-calibrating micro-volume, in-line pH monitor
HORIBA, an OEM of instruments and measurement systems, has launched the UP-100, a micro-volume in-line pH monitor which has uses in several applications and sectors including bio reactors, food and drink processing, pharmaceutical, chemical manufacturing and the semiconductor industry...
Agilent Technologies acquires raman spectroscopy innovator, Cobalt Light Systems
Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers...
NICE recommends cabozantinib for advanced renal cell cancer
The National Institute for Health and Care Excellence (NICE) has issued final guidance recommending cabozantinib for some kidney cancer patients
Mindfulness-based therapy may reduce stress in obese patients
In a randomised clinical trial of women who were overweight or obese, mindfulness-based stress reduction (MBSR) increased mindfulness and decreased stress compared with health education.
Vitamin D may improve sunburn, says new trial
High doses of vitamin D taken one hour after sunburn significantly reduce skin redness, swelling, and inflammation, according to double-blinded, placebo-controlled clinical trial out of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center. Study specifics In the study, 20 participants were randomised to receive a…
Brain training app improves memory in people with cognitive impairment
A brain training game could help improve the memory of patients in the very earliest stages of dementia, suggests a study.
Novartis combination targeted therapy receives FDA approval
The FDA has approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat patients with metastatic non-small cell lung cancer.
Study predicts 1.2 million people in UK will be living with dementia by 2040
By 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), due to increased life expectancy...
Wickham Laboratories now offering full suite of medical device biocompatibility and safety testing
Wickham Laboratories is pleased to announce the extension of its medical device testing services...
Heart failure market worth $16 billion by 2026 as Novartis’ drug triggers growth
The heart failure space across the seven key markets of the US, France, Germany, Italy, Spain, the UK and Japan is set to grow from $3.7 billion in 2016 to around $16.1 billion by 2026, representing an impressive compound annual growth rate of 15.7%, according to research and consulting firm…
Patheon to invest $45 million in spray drying & manufacturing solutions
Patheon expects to invest approximately $45 million at key sites across its network in spray drying capabilities and flexible manufacturing solutions...
ABPI respond to statement of UK Government’s medicines regulation plans
The ABPI has responded to a joint letter from Jeremy Hunt, Secretary of State for Health, and Greg Clark, Secretary of State for Business, published by the Financial Times, that outlined the UK Government’s plans for the regulation of medicines as the UK leaves the European Union (EU).
NICE recommends Lilly’s Baricitinib (Olumiant) to treat rheumatoid arthritis
Baricitinib is the first JAK inhibitor to be recommended by NICE to treat rheumatoid arthritis in adults who have not responded to conventional therapy…
Sandoz receives EU approval in Europe for Rixathon (biosimilar rituximab)
The EC has approved Sandoz’ Rixathon (biosimilar rituximab) for use in Europe. Rixathon is approved for use in all indications of the reference medicine...
